Continuous Glucose Monitor

|

18

Medtronic and Novo Nordisk Team Up to Link Smart Insulin Pens to CGMs

Medtronic and Novo Nordisk announced earlier this week a collaboration to integrate insulin dosing data from future Novo Nordisk smart insulin pens …

| |

Dexcom G6® CGM System Now Available In Canada

DexCom Inc., a developer of continuous glucose monitoring (CGM) systems, announced today that it is now accepting orders for the Dexcom G6 CGM …

LifeScan and Sanvita Medical Partner to Launch Continuous Glucose Monitoring Devices

LifeScan, a leader in blood glucose monitoring and maker of the OneTouch® brand announced it has entered into an exclusive agreement with Sanvita …

|

DarioHealth Partners With Glytec on Outpatient Diabetes Management

DarioHealth Corp., today announced a joint marketing agreement with Glytec, a pioneer of insulin titration solutions. The agreement allows …

Senseonics Launches New Patient Access Program in the U.S.

Senseonics Holdings, Inc., a medical technology company developing a long-term, implantable continuous glucose monitoring (CGM) system for people …

Senseonics Eversense® CGM Integrates with Glooko Diabetes Management Platform

Senseonics Holdings, Inc. announced the integration of Eversense CGM data into the Glooko diabetes data management platform. Senseonics is focused on …

|

Abbott and Novo Nordisk Partner to Provide Digital Solution for Those Using Insulin

Abbott and Novo Nordisk today announced a deal that connects two key technologies: Continuous glucose monitoring (CGM) and connected insulin pens. …

|

Senseonics Partners with Geo-Med to Provide Veterans Access to CGM

Senseonics Holdings, Inc., a company developing long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, announced …

|

Senseonics and Roche Diabetes Care Extend Distribution Agreement to More Countries

Senseonics Holdings, Inc., announced it will extend its agreement with Roche Diabetes Care to sell its implantable continuous glucose monitoring …

|

FDA Approves Mobile App for Abbott’s Freestyle Libre

A new mobile app for Abbott’s Freestyle Libre 10-day and 14-day glucose monitoring systems has been approved for use in the U.S. by the FDA. It …